Pangenomic Health Inc. (NARA.CN)
CAD 0.14
(0.0%)
CAD 0.14
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 71.47 Thousand CAD | -85.82% |
| 2022 | 504.14 Thousand CAD | -80.44% |
| 2021 | 2.57 Million CAD | 1650.33% |
| 2020 | 147.22 Thousand CAD | 2525.27% |
| 2019 | 5608.00 CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 62.04 Thousand CAD | -24.7% |
| 2024 Q1 | 82.38 Thousand CAD | 15.26% |
| 2023 Q1 | 437.5 Thousand CAD | -13.22% |
| 2023 FY | 71.47 Thousand CAD | -85.82% |
| 2023 Q4 | 71.47 Thousand CAD | -57.68% |
| 2023 Q3 | 168.91 Thousand CAD | -21.69% |
| 2023 Q2 | 215.7 Thousand CAD | -50.7% |
| 2022 Q1 | 2.01 Million CAD | -21.98% |
| 2022 FY | 504.14 Thousand CAD | -80.44% |
| 2022 Q4 | 504.14 Thousand CAD | -66.76% |
| 2022 Q3 | 1.51 Million CAD | -39.47% |
| 2022 Q2 | 2.5 Million CAD | 24.61% |
| 2021 Q3 | 214.14 Thousand CAD | 0.0% |
| 2021 Q1 | - CAD | -100.0% |
| 2021 Q4 | 2.57 Million CAD | 1103.36% |
| 2021 FY | 2.57 Million CAD | 1650.33% |
| 2020 FY | 147.22 Thousand CAD | 2525.27% |
| 2020 Q4 | 147.22 Thousand CAD | 0.0% |
| 2019 FY | 5608.00 CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AI/ML Innovations Inc. | 329.68 Thousand CAD | 78.32% |
| Diagnamed Holdings Corp. | 662.27 Thousand CAD | 89.207% |
| nDatalyze Corp. | 877.9 Thousand CAD | 91.858% |
| Treatment.Com International Inc. | 739.3 Thousand CAD | 90.332% |
| Unidoc Health Corp. | 517.08 Thousand CAD | 86.177% |